Homepage > Company > Media > Pharma News > 2021 > Lupin launches generic diarrhea drug in US market

Lupin launches generic diarrhea drug in US market

Drug major Lupin on Wednesday said it has launched Nitazoxanide tablets (500 mg), used to treat diarrhea, in the US market.

The company's product is the generic version of Romark Laboratories' Alinia Tablets, 500 mg, Lupin said in a statement.

Nitazoxanide tablets, 500 mg, are indicated in the treatment of diarrhea caused by Giardia lamblia or Cryptosporidium parvum in patients 12 years of age and older.

As per IQVIA moving annual total (MAT) January 2021 data, Nitazoxanide tablets had estimated annual sales of USD 56 million in the US.

March 10, 2021

https://health.economictimes.indiatimes.com/

Read also

Spinogenix’s ALS hopeful to advance to registrational trial

Spinogenix’s first-in-class ALS treatment, SPG302 has been shown to slow disease progression in 82% of patients during a Phase IIa study.

FDA Approves First Treatment for Rare Thymidine Kinase 2 Deficiency

Thymidine kinase 2 deficiency (TK2d) is an ultra-rare (1.64 cases per 1,000,000 people) often fatal, genetic mitochondrial disease characterized by progressive and severe muscle weakne...

Cencora

Cencora to invest $1bn in US pharma distribution network

Celltrion

Celltrion Signs Licensing Deal with U.S. Kaigene for Two Antibody Drug Candidates